A detailed history of Morgan Stanley transactions in Generation Bio Co. stock. As of the latest transaction made, Morgan Stanley holds 999,671 shares of GBIO stock, worth $1.37 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
999,671
Previous 936,396 6.76%
Holding current value
$1.37 Million
Previous $2.64 Million 6.48%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.16 - $3.51 $136,674 - $222,095
63,275 Added 6.76%
999,671 $2.47 Million
Q2 2024

Oct 17, 2024

SELL
$2.64 - $4.35 $14,219 - $23,429
-5,386 Reduced 0.57%
936,396 $2.64 Million
Q2 2024

Aug 14, 2024

SELL
$2.64 - $4.35 $14,219 - $23,429
-5,386 Reduced 0.57%
936,396 $2.64 Million
Q1 2024

Oct 17, 2024

BUY
$1.73 - $4.07 $9,317 - $21,921
5,386 Added 0.58%
941,782 $3.83 Million
Q1 2024

Aug 16, 2024

SELL
$1.73 - $4.07 $211,547 - $497,687
-122,282 Reduced 11.49%
941,782 $3.83 Million
Q1 2024

May 15, 2024

SELL
$1.73 - $4.07 $211,547 - $497,687
-122,282 Reduced 11.49%
941,782 $3.83 Million
Q4 2023

Aug 16, 2024

BUY
$0.91 - $3.35 $116,177 - $427,687
127,668 Added 13.63%
1,064,064 $1.76 Million
Q4 2023

Feb 13, 2024

BUY
$0.91 - $3.35 $510,595 - $1.88 Million
561,094 Added 111.56%
1,064,064 $1.76 Million
Q3 2023

Nov 15, 2023

SELL
$3.65 - $6.9 $77,569 - $146,638
-21,252 Reduced 4.05%
502,970 $1.91 Million
Q2 2023

Aug 14, 2023

BUY
$3.5 - $5.67 $36,498 - $59,126
10,428 Added 2.03%
524,222 $2.88 Million
Q1 2023

May 15, 2023

BUY
$3.61 - $7.01 $78,762 - $152,944
21,818 Added 4.43%
513,794 $2.21 Million
Q4 2022

Feb 14, 2023

BUY
$3.66 - $6.77 $18,636 - $34,472
5,092 Added 1.05%
491,976 $1.93 Million
Q3 2022

Nov 14, 2022

BUY
$4.68 - $8.34 $1.32 Million - $2.36 Million
283,067 Added 138.88%
486,884 $2.59 Million
Q2 2022

Oct 27, 2022

SELL
$4.87 - $9.41 $46,420 - $89,696
-9,532 Reduced 4.47%
203,817 $1.34 Million
Q2 2022

Aug 15, 2022

SELL
$4.87 - $9.41 $46,420 - $89,696
-9,532 Reduced 4.47%
203,817 $1.34 Million
Q1 2022

Oct 27, 2022

BUY
$4.16 - $7.76 $39,653 - $73,968
9,532 Added 4.68%
213,349 $1.57 Million
Q1 2022

May 13, 2022

SELL
$4.16 - $7.76 $128,136 - $239,023
-30,802 Reduced 12.62%
213,349 $1.57 Million
Q4 2021

Feb 14, 2022

BUY
$5.99 - $24.97 $44,056 - $183,654
7,355 Added 3.11%
244,151 $1.73 Million
Q3 2021

Nov 15, 2021

BUY
$20.0 - $27.43 $4.74 Million - $6.5 Million
236,796 New
236,796 $5.94 Million

Others Institutions Holding GBIO

About Generation Bio Co.


  • Ticker GBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,011,200
  • Market Cap $80.8M
  • Description
  • Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...
More about GBIO
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.